ARTICLE | Clinical News
Leukine sargramostim regulatory update
May 26, 2008 7:00 AM UTC
Bayer said FDA approved reformulated version of liquid Leukine sargramostim 500 µg to treat acute myelogenous leukemia (AML). The new formulation, which does not contain edetate disodium (EDTA), is no...